Rigel Pharma (RIGL) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $36.55 --0%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
YRD, NNOX, BB, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
YRD, NNOX, BB, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $29.8 million versus the consensus estimate of $23.82 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
